便秘治疗市场规模、份额和成长分析（按治疗方法、给药途径、患者类型、通路和地区划分）—2026-2033年行业预测

全球便秘治疗市场规模预计在 2024 年达到 193.1 亿美元，从 2025 年的 204.9 亿美元增长到 2033 年的 329 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.1%。

全球便秘治疗市场正经历显着成长，这主要得益于几个关键因素。人口老化导致慢性便秘和胃肠道疾病的盛行率上升，而阿片类药物使用量的增加又导致阿片类药物引起的便秘病例激增，从而推动了对标靶治疗方法的需求。消费者越来越多地转向非处方天然产品，这一趋势也得益于人们对肠道健康的日益关注。此外，数位健康管理和远距医疗等技术的进步提高了诊断和治疗水平，进一步推动了市场发展。然而，挑战依然存在，包括泻药副作用导致的患者依从性问题、经济欠发达地区认知度低、治疗费用高昂以及监管障碍导致产品上市延迟等，这些都为现有企业和新参与企业创造了复杂的市场环境。

推动全球便秘治疗市场发展的因素

大肠激躁症和慢性特发性便秘等胃肠道疾病的日益普遍是便秘治疗市场的主要驱动力。造成这现象的因素包括久坐的生活方式、不良的饮食习惯以及人口老化。这些因素共同导致便秘相关疾病的发生率上升，并推动了对处方药和非处方药的需求。人们对这些疾病的认识不断提高，加上健康促进意识的增强，预计将确保对有效便秘治疗的需求保持强劲，从而推动市场的进一步发展和创新。

限制全球便秘治疗市场的因素

全球便秘治疗市场面临长期使用泻药和某些处方药的挑战，这些药物常常会引起成瘾、电解质失衡和胃肠道不适等副作用，从而降低患者对治疗方案的依从性，并阻碍长期管理策略的整体疗效。这种情况促使人们转向更容易接受且更安全的便秘治疗方法，同时也推动了非药物疗法的研发和应用。因此，医疗保健专业人员面临越来越大的压力，需要探索并优先选择治疗方法。

全球便秘治疗市场趋势

在全球便秘治疗市场，个人化肠道健康解决方案正日益普及，这主要得益于微生物组研究和人工智慧技术的进步。这一趋势反映出治疗方式正发生重大转变，即更加重视个体化的治疗方案，以应对个别肠道菌丛、生活方式因素以及持续的症状追踪。针对特定患者需求量身定制的干预措施旨在提高治疗效果、增强患者依从性并改善整体治疗结果。随着科技在医疗保健领域的日益融合，个人化治疗的兴起代表着便秘管理领域的一个变革性方向，与整个医疗保健领域以患者为中心的护理和精准医疗的更广泛趋势相契合。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球便秘治疗市场规模（依治疗方法划分）及复合年增长率（2026-2033 年）

• 药理学
  • 泻药
  • 氯离子通道活化剂
  • GC-C促效剂
  • 5-HT4促效剂
  • 週边作用的μ-阿片受体拮抗剂
  • 其他的
• 非药物疗法
  • 膳食纤维补充剂
  • 生物回馈疗法和物理疗法
  • 粪便微生物移植
  • 数位疗法

全球便秘治疗市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 口服
• 直肠给药
• 肠外/皮下给药

全球便秘治疗市场规模（依病患类型划分）及复合年增长率（2026-2033 年）

• 成人
• 儿童
• 老年人

全球便秘治疗市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

• 医院药房
• 零售药局和药局
• 网路药房

全球便秘治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• AbbVie Inc.（United States）
• Takeda Pharmaceutical Company（Japan）
• Bausch Health Companies Inc.（Canada）
• Ironwood Pharmaceuticals（United States）
• Sanofi（France）
• Bayer（Germany）
• GlaxoSmithKline（United Kingdom）
• Johnson & Johnson（United States）
• Procter & Gamble（United States）
• Shionogi & Co., Ltd.（Japan）
• Cipla（India）
• AstraZeneca（United Kingdom）
• Boehringer Ingelheim GmbH（Germany）
• Prestige Consumer Healthcare Inc.（United States）
• Nestle Health Science（Switzerland）
• Ardelyx Inc.（United States）
• Mallinckrodt Pharmaceuticals（Ireland）
• Sun Pharmaceutical Industries Ltd.（India）
• Cosmo Pharmaceuticals（Ireland）
• CB Fleet Company Inc.（United States）

结论与建议

Global Constipation Treatment Market size was valued at USD 19.31 Billion in 2024 and is poised to grow from USD 20.49 Billion in 2025 to USD 32.9 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The global constipation treatment market is experiencing significant growth driven by several key factors. An aging population has led to an increased prevalence of chronic constipation and gastrointestinal disorders, while a rise in opioid usage has resulted in a surge of opioid-induced constipation cases, escalating the need for targeted treatments. Consumers are increasingly favoring over-the-counter natural products, a trend supported by heightened awareness of gut health. Additionally, advancements in technology, such as digital health tracking and teleconsultation, are improving diagnosis and management, further fueling market momentum. However, challenges persist, including patient compliance issues due to laxative side effects, low awareness in economically disadvantaged areas, high therapy costs, and regulatory hurdles that slow product launches, complicating the landscape for both established companies and new entrants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Constipation Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Constipation Treatment Market Segments Analysis

Global Constipation Treatment Market is segmented by Treatment Type, Route of Administration, Patient Type, Distribution Channel and region. Based on Treatment Type, the market is segmented into Pharmacological and Non-Pharmacological. Based on Route of Administration, the market is segmented into Oral, Rectal and Parenteral / Sub-cutaneous. Based on Patient Type, the market is segmented into Adults, Pediatrics and Geriatrics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Constipation Treatment Market

The rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome and chronic idiopathic constipation, significantly propels the growth of the constipation treatment market. Contributing factors include sedentary lifestyles, poor dietary choices, and an increasingly aging demographic. These elements combine to create a higher incidence of constipation-related issues, which in turn fuels the demand for both prescription and over-the-counter treatment options. As awareness of these conditions grows, coupled with a focus on improved health and wellness, it is anticipated that the need for effective constipation treatments will remain robust, driving further developments and innovations within the market.

Restraints in the Global Constipation Treatment Market

The Global Constipation Treatment market faces challenges due to the prolonged use of laxatives and certain prescription medications, which often lead to adverse effects such as dependency, electrolyte imbalances, and gastrointestinal discomfort. These complications tend to reduce patient adherence to treatment regimens, inhibiting the overall effectiveness of long-term management strategies. Consequently, this situation is prompting a shift toward more acceptable and safer alternatives in constipation care, while simultaneously fostering the development and adoption of non-pharmacological therapies. As a result, healthcare providers are increasingly encouraged to explore and prioritize treatment options that minimize potential side effects and enhance patient well-being.

Market Trends of the Global Constipation Treatment Market

The Global Constipation Treatment market is increasingly embracing personalized gut health solutions, driven by advancements in microbiome research and artificial intelligence. This trend reflects a significant shift toward customized treatment options that cater to individual gut profiles, lifestyle factors, and ongoing symptom tracking. By tailoring interventions to meet specific patient needs, the market aims to enhance treatment efficacy and boost patient adherence, thereby improving overall outcomes. As technology continues to integrate into healthcare, the emphasis on personalization signifies a transformative direction in constipation management, aligning with broader trends in patient-centered care and precision medicine within the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Constipation Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological
  • Laxatives
  • Chloride Channel Activators
  • GC-C Agonists
  • 5-HT4 Agonists
  • Peripherally Acting µ-Opioid Receptor Antagonists
  • Others
• Non-Pharmacological
  • Dietary Fiber Supplements
  • Biofeedback & Physical Therapy
  • Fecal Microbiota Transplant
  • Digital Therapeutics

Global Constipation Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Rectal
• Parenteral / Sub-cutaneous

Global Constipation Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatrics
• Geriatrics

Global Constipation Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Constipation Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ironwood Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shionogi & Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardelyx Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmo Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B. Fleet Company Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations